TY - JOUR
T1 - The effect of dilution on plasma coagulation kinetics determined by thrombelastography is dependent on antithrombin activity and mode of activation
AU - Nielsen, Vance G.
AU - Lyerly, Ralph T.
AU - Gurley, William Q.
PY - 2004/12
Y1 - 2004/12
N2 - Hemodilution-associated hypercoagulability has been the focus of several investigations because significant morbidity and mortality have been associated with perioperative thrombophilia. Because most investigations implicate imbalances in procoagulant/anticoagulant activity as the etiology of hemodilution-associated hypercoagulability, we determined the effects of dilution on coagulation kinetics and clot strength with thrombelastography (TEG®). Control plasma (± celite activation) and antithrombin (AT)-deficient (<10% activity) plasma were diluted 0%, 10%, 20%, and 30% with saline. TEG® variables measured included time to clot initiation (reaction time, R), speed of clot propagation (angle, α), and clot strength (amplitude, A; or shear elastic modulus, G). Dilution of control plasma (10%-30%) resulted in a significant (P < 0.05) 16% decrease in R values, no change in α values, and decrease in A and G values. AT-deficient plasma had significantly smaller R values compared with control, and dilution did not change R values in AT-deficient plasma. Celite activation eliminated dilution-associated changes in R values in control plasma but resulted in linear decreases (R2 = 0.88-0.96, P < 0.0001) in α, A, and G in response to dilution. Thus, our data indirectly support the concept that decreases in AT activity cause dilution-mediated hypercoagulability in plasma. Finally, celite activation permits quantification of dilution with TEG®.
AB - Hemodilution-associated hypercoagulability has been the focus of several investigations because significant morbidity and mortality have been associated with perioperative thrombophilia. Because most investigations implicate imbalances in procoagulant/anticoagulant activity as the etiology of hemodilution-associated hypercoagulability, we determined the effects of dilution on coagulation kinetics and clot strength with thrombelastography (TEG®). Control plasma (± celite activation) and antithrombin (AT)-deficient (<10% activity) plasma were diluted 0%, 10%, 20%, and 30% with saline. TEG® variables measured included time to clot initiation (reaction time, R), speed of clot propagation (angle, α), and clot strength (amplitude, A; or shear elastic modulus, G). Dilution of control plasma (10%-30%) resulted in a significant (P < 0.05) 16% decrease in R values, no change in α values, and decrease in A and G values. AT-deficient plasma had significantly smaller R values compared with control, and dilution did not change R values in AT-deficient plasma. Celite activation eliminated dilution-associated changes in R values in control plasma but resulted in linear decreases (R2 = 0.88-0.96, P < 0.0001) in α, A, and G in response to dilution. Thus, our data indirectly support the concept that decreases in AT activity cause dilution-mediated hypercoagulability in plasma. Finally, celite activation permits quantification of dilution with TEG®.
UR - http://www.scopus.com/inward/record.url?scp=9244252037&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=9244252037&partnerID=8YFLogxK
U2 - 10.1213/01.ANE.0000136843.58799.AB
DO - 10.1213/01.ANE.0000136843.58799.AB
M3 - Article
C2 - 15562037
AN - SCOPUS:9244252037
SN - 0003-2999
VL - 99
SP - 1587
EP - 1592
JO - Anesthesia and analgesia
JF - Anesthesia and analgesia
IS - 6
ER -